Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: Acutus medical | Mind Blowing Facts

Acutus Medical's Return On Capital Employed Overview

Benzinga Pro data, Acutus Medical (NASDAQ:AFIB) reported Q1 sales of $3.68 million. Earnings fell to a loss of $40.02 million, resulting in a 28.0% decrease from last quarter.

Acutus Medical Completes Patient Enrolment In AcQForce Flutter IDE Trial

Acutus Medical Completes Patient Enrolment In AcQForce Flutter IDE Trial

Acutus Medical (NASDAQ: AFIB) completed patient enrollment in the AcQForce Flutter Investigational Device Exemption (IDE) clinical trial. The trial was designed to evaluate the safety and efficacy of the AcQBlate FORCE sensing ablation catheter and system in the treatment of right atrial typical flutter.

Recap: Acutus Medical Q1 Earnings

Recap: Acutus Medical Q1 Earnings

Acutus Medical (NASDAQ:AFIB) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Acutus Medical missed estimated earnings by 8.7%, reporting an EPS of $-1.0 versus an estimate of $-0.92.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Is Acutus Medical a Winning Medical Device Stock?

Arrhythmia management company Acutus Medical (AFIB) recently announced it had received a commitment letter from Deerfield Management Company to refinance its existing debt with a new longer-term credit facility. The news pushed its share price higher. However, considering the bearish analysts’ sentiments around the company’s near-term prospects, would it be…

Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2022

12 Health Care Stocks Moving In Thursday's Intraday Session

Here's Why Acutus Medical Shares Are Falling

Acutus Medical Inc (NASDAQ: AFIB) shares are trading lower by 20.8% at $1.53 after the company reported worse-than-expected fourth-quarter EPS results and issued first-quarter sales guidance below analyst estimates.

inkl

Read news from The Economist, FT, and more,
with one subscription

Acutus Medical Earnings Perspective: Return On Capital Employed

Acutus Medical Earnings Perspective: Return On Capital Employed

Acutus Medical (NASDAQ:AFIB) brought in sales totaling $4.36 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 9.66%, resulting in a loss of $31.26 million.

5 Stocks To Watch For March 31, 2022

5 Stocks To Watch For March 31, 2022

Some of the stocks that may grab investor focus today are:

Acutus Medical: Q4 Earnings Insights

Acutus Medical: Q4 Earnings Insights

Acutus Medical (NASDAQ:AFIB) reported its Q4 earnings results on Wednesday, March 30, 2022 at 04:01 PM. Here's what investors need to know about the announcement.

Earnings Outlook For Acutus Medical

Earnings Outlook For Acutus Medical

Acutus Medical (NASDAQ:AFIB) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that Acutus Medical will report an earnings per share (EPS) of $-0.83.

Acutus Medical's Earnings Outlook

Acutus Medical's Earnings Outlook

Acutus Medical (NASDAQ:AFIB) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts estimate that Acutus Medical will report an earnings per share (EPS) of $-0.83.

1

Organisations

B of A Securities

JetBlue Airways

Capital One Financial

Bank of New York Mellon

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play